Ftse Mib
34.339,32
0,55%
DAX
18.686,60
1,07%
S&P 500
5.214,08
0,51%
NASDAQ
16.346,26
0,27%
Bitcoin
63.027,04
3,01%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cytek Biosciences Inc (CTKB) Cytek Biosciences Inc (CTKB) Notizie

CTKB

Cytek Biosciences (CTKB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CTKB
DataOraFonteTitoloSimboloCompagnia
08/05/202422:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTKBCytek Biosciences Inc
08/05/202422:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
08/05/202422:05GlobeNewswire Inc.Cytek Biosciences Reports First Quarter 2024 Financial ResultsNASDAQ:CTKBCytek Biosciences Inc
30/04/202423:30GlobeNewswire Inc.Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and EuropeNASDAQ:CTKBCytek Biosciences Inc
29/04/202415:00GlobeNewswire Inc.Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:CTKBCytek Biosciences Inc
19/03/202413:00GlobeNewswire Inc.Cytek® Biosciences Names William McCombe Chief Financial OfficerNASDAQ:CTKBCytek Biosciences Inc
09/03/202400:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
07/03/202423:30GlobeNewswire Inc.Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis SolutionsNASDAQ:CTKBCytek Biosciences Inc
28/02/202423:05GlobeNewswire Inc.Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 OutlookNASDAQ:CTKBCytek Biosciences Inc
14/02/202422:07Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CTKBCytek Biosciences Inc
07/02/202422:10GlobeNewswire Inc.Cytek Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CTKBCytek Biosciences Inc
07/02/202422:05GlobeNewswire Inc.Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:CTKBCytek Biosciences Inc
17/01/202423:30GlobeNewswire Inc.Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific DiscoveriesNASDAQ:CTKBCytek Biosciences Inc
08/01/202415:00GlobeNewswire Inc.Cytek Biosciences Announces Preliminary Full Year 2023 Revenue ResultsNASDAQ:CTKBCytek Biosciences Inc
28/12/202322:05GlobeNewswire Inc.Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
21/12/202315:00GlobeNewswire Inc.Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow CytometryNASDAQ:CTKBCytek Biosciences Inc
19/12/202322:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CTKBCytek Biosciences Inc
14/11/202322:05GlobeNewswire Inc.Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
13/11/202322:02Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:CTKBCytek Biosciences Inc
08/11/202315:00GlobeNewswire Inc.Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’NASDAQ:CTKBCytek Biosciences Inc
07/11/202322:05GlobeNewswire Inc.Cytek Biosciences Reports Third Quarter 2023 Financial ResultsNASDAQ:CTKBCytek Biosciences Inc
19/10/202322:05GlobeNewswire Inc.Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:CTKBCytek Biosciences Inc
27/09/202315:00GlobeNewswire Inc.Cytek® Biosciences Achieves ISO 13485 Certification at HeadquartersNASDAQ:CTKBCytek Biosciences Inc
20/09/202322:15GlobeNewswire Inc.Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
20/09/202315:00GlobeNewswire Inc.Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and EuropeNASDAQ:CTKBCytek Biosciences Inc
14/09/202315:00GlobeNewswire Inc.Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow CytometryNASDAQ:CTKBCytek Biosciences Inc
06/09/202322:10GlobeNewswire Inc.Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
30/08/202300:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
28/08/202311:30GlobeNewswire Inc.Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & ServicesNASDAQ:CTKBCytek Biosciences Inc
10/08/202322:05GlobeNewswire Inc.Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics SummitNASDAQ:CTKBCytek Biosciences Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CTKB

La tua Cronologia

BIT
BPE
Bper Banca
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
NEXI
Nexi S.p.A
BIT
BAMI
Banco BPM
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
FBK
Finecobank
BIT
TIT
Telecom Italia
BIT
SRG
Snam
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network